APAO 2026 successfully concluded from February 5 to 8, 2026, at the Hong Kong Convention and Exhibition Centre.
As one of the most authoritative and influential academic events in ophthalmology across the Asia-Pacific region, this year’s congress gathered top ophthalmic experts, clinicians,
and industry elites from around the world under the official theme “Eyes on the Future: Innovating Ophthalmology”, building a premium platform for in-depth academic exchange and close industry collaboration.


Mediworks made a distinguished appearance at APAO 2026 with a series of cutting-edge ophthalmic equipment, headlined by the grand launch of the new-generation Elanus M Ophthalmic Surgical Microscope.
Alongside this flagship product, the company also showcased the MarveLens Non-Contact Wide-Angle Fundus Viewing System, AL550 Optical Biometer, and Scansys Pro 3D Anterior Segment Analyzer.
Engineered to deliver sharper visual details, more precise quantitative data, and smarter clinical auxiliary functions, these innovative devices provide solid decision-making support
for eye health diagnosis and treatment, helping to boost the efficiency and accuracy of clinical practice.

In addition to its core innovative products, MediWorks presented its full range of professional ophthalmic equipment at the exhibition, covering the DEA520 Dry Eye & Corneal Topographer, FC162 Fundus Camera,
V100 Vision Screener, and the star product S390L (Firefly) Slit Lamp Microscope with D131 Dry Eye Module. This comprehensive portfolio creates an integrated solution for ocular surface diagnosis and treatment,
optometry screening, and fundus examination, fully demonstrating MediWorks’s professional capabilities and technical strength in the fields of ophthalmic diagnosis and optometry.

We sincerely thank all global industry partners, colleagues, and visitors for stopping by MediWorks’s booth Hall 5FG-L05 to experience our advanced equipment, exchange technical insights, and explore potential cooperation opportunities.
MediWorks will continue to focus on innovative research and development in ophthalmic technology, and is committed to deepening global partnerships to jointly promote the high-quality development of global eye health care.